What is Ostarine MK-2866? Know More About Ostarine Benefits in This Ostarine MK-2866 Guide
Ostarine (MK-2866), additionally known as Enobosarm, is a selective androgen receptor modulator (SARM). SARMs like Ostarine stimulate androgen hormone receptors similar to the way in which naturally produced androgens (i.e. testosterone) do.
In comparison to anabolic steroids (anabolic-androgenic steroids, or “AAS”), which bind rather non- selectively to androgen receptors on many body tissues (prostate, scalp, skeletal muscle, etc.), SARMs can target particular tissues, which mainly include skeletal muscle and bone. Research has shown this to limit undesirable side effects. Research on SARMs also suggests that SARMs are (relatively speaking) less suppressive of endogenous (natural) testosterone production. However, SARMs can still be suppressive, and the variables include individual research subject response, dosage, and duration. SARMs do not aromatize (convert) to estrogen like testosterone and many steroids do, further limiting potential for side effects. For these reasons, among others, it is thought that SARM safety is higher than the safety of traditional anabolic steroids. Simultaneously, it is thought that SARMs gains in research applications compared with SARMs side effects is very favorable.
Ostarine is ((2 S)-3-(4-cyanophenoxy)- N -[4-cyano-3-(trifluoromethyl) phenyl]-2-hydroxy-2-methylpropanamide), popularly known as MK-2866, GTX-024 and Enobosarm. Overall, research shows significant promise for muscle wasting and bone density issues. It appears that SARMs, including Ostarine, has made its way into various sports such as bodybuilding and fitness, strength sports, and endurance sports, among others due to reported improvements in muscle strength, size, and recovery.
Ostarine MK-2866 Benefits:
The following benefits of MK-2866 are derived from currently available clinical research and other scientific literature.
Ostarine – Increase Lean Muscle and Decrease Fat Mass:
Research on Ostarine continues to be investigated for cancer subjects, HIV subjects, subjects with wasting diseases, and older subjects that experience muscle loss and muscular atrophy.
In a clinical study with MK-2866, a sample group of 120 older subjects were administered 3mg of Ostarine every day for 12 weeks. Toward the finish of the study, the subjects experienced improved wellness and gained more lean muscle tissue than the controls subjects. The subjects gain an average of 1.3kg lean weight (2.8 lbs), without exercise. The subjects also lost 0.6kg (0.3 lbs) of fat mass while on Ostarine. MK-2866 caused muscle gain and fat loss in these subjects. Adverse side effects in this study were rare, and/or not observed in the subjects.
Ostarine & Improved Insulin Sensitivity:
Enobosarm has shown to potentially decrease blood glucose and improve insulin sensitivity. These are similar impacts that anti-diabetic medications like metformin. Further research is required to demonstrate the advantages of Enobosarm on metabolic disorders and diabetes, however this is an interesting and significant benefit of MK-2866
Ostarine & Increased Bone Density:
Age is correlated with decreased bone density, which significantly increases the risk of hip fracture and other ailments. Part of this process is due to a decrease in the natural production of sex hormones like testosterone and estrogen.
If left untreated, subjects often experience osteoporosis and other bone related issues. One approach to battle such weakening is to improve bone mineralization and increase muscle mass.
Research on Ostarine has shown many benefits, including the potential to prevent and possibly treat bone illnesses and assist with recovery from bone fractures.